City
Epaper

Quantum computing, AI to revolutionise drug discovery in India: Ex-ICMR chief

By IANS | Updated: February 20, 2025 16:35 IST

New Delhi, Feb 20 Quantum computing and Artificial Intelligence (AI) to revolutionise drug discovery in India, and enable ...

Open in App

New Delhi, Feb 20 Quantum computing and Artificial Intelligence (AI) to revolutionise drug discovery in India, and enable the country to become a global hub for pharmaceutical advancements, said Dr. Balram Bhargava, Former Director General, ICMR.

He was speaking at the 9th "International Symposium on Current Trends in Drug Discovery Research” at CSIR-Central Drug Research Institute, Lucknow.

“India's strength in drug discovery stems from its rich heritage in chemistry, making it a global hub for pharmaceutical advancements,” said Bhargava, Dean and Senior Consultant, Holy Family Hospital, New Delhi.

“The integration of Quantum Computing and Artificial Intelligence (AI) is set to revolutionise drug discovery, accelerating research and reducing costs,” he added.

The expert noted that India has consistently demonstrated its ability to produce high-quality, affordable medicines, ensuring healthcare accessibility worldwide. However, challenges such as the availability of Active Pharmaceutical Ingredients (APIs) and the need for new drug discoveries remain key areas of focus.

Further, Bhargava called for collaborations to boost India's pharmaceutical success, as seen in the development of vaccines.

“Market shaping is equally important, ensuring that innovations reach the masses while maintaining India's leadership in cost-effective healthcare solutions,” he said.

The event, aimed to discuss new strategies in synthetic and medicinal chemistry in the country, also witnessed the presence of global experts from the universities of Florida and Minnesota in the US. They spoke on breakthroughs in pain management strategies as well as the need to develop new antimicrobial agents with novel mechanisms.

Meanwhile, Dr. Arindam Talukdar from CSIR-Indian Institute of Chemical Biology (IICB), Kolkata, shared his research findings on the stimulation of agonism-antagonism in TLR7 modulators via complex interactions between chemical subunits.

The TLR7 is an endosomal TLR protein that helps the body to recognise and respond to viruses and bacteria.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

NationalSIR exercise: Over 30 lakh enumeration forms distributed across Rajasthan in 2 days

NationalBJP’s new state committee in West Bengal might be announced by end of next week

NationalManipur: Large cache of arms seized, two drug peddlers held with brown sugar

Cricket"Have really loved watching Xavier...": Ex-Aussie pacer on young Queensland star

NationalRahul Gandhi’s ‘vote-chori’ claim faces pushback as Haryana woman denies allegation

Technology Realted Stories

TechnologyDelhivery slips into losses despite posting 17 pc revenue rise in Q2 FY26

TechnologyMahindra’s commercial EV manufacturer surpasses 3 lakh sales milestone

TechnologyScience, R&D, advanced materials key pillars for Viksit Bharat 2047: CSIR

TechnologyMyntra ‘GlamStream Fest’ set to build India’s most vibrant fashion and beauty ecosystem

Technology100 5G labs set up across India to boost 6G research ecosystem: Govt